2011 Nov 4 [updated 2011 Dec 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
PMID:22171396
Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
Hawkins PN, Lavender JP, Pepys MB.
N Engl J Med. 1990 Aug 23;323(8):508-13. doi: 10.1056/NEJM199008233230803.
PMID:2377176
Novel styrylbenzene derivatives for detecting amyloid deposits.
Nakazono M, Obayashi K, Sasamoto K, Tomiyoshi K, Suenaga G, Ando Y.
2011 Nov 2 [updated 2011 Dec 1]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
PMID:22171393
Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis.
Martin EB, Williams A, Richey T, Stuckey A, Heidel RE, Kennel SJ, Wall JS.
Sci Rep. 2016 Mar 3;6:22695. doi: 10.1038/srep22695.
PMID:26936002
Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature.
Babu A, Lachmann H, Pickett T, Boddana P, Ludeman L.
CEN Case Rep. 2014 May;3(1):68-74. doi: 10.1007/s13730-013-0088-8. Epub 2013 Aug 9.
PMID:28509249
Natural history and outcome in systemic AA amyloidosis.